E-LIB Suche - Ergebnisse für: Barbaliscia, S.

1

Analysis of resistance and phylogenetic clusters in HCV-2c ..:

Barbaliscia, S. ; Di Maio, V.C. ; Fabeni, L....
Digestive and Liver Disease. 52 (2020) - p. e24-e25 , 2020

Link: https://doi.org/10.1016/..

2

VIRONET-C real life experience of resistance-guided retreat..:

Di Maio, V.C. ; Aragri, M. ; Masetti, C....
Digestive and Liver Disease. 52 (2020) - p. e2-e3 , 2020

Link: https://doi.org/10.1016/..

3

Characterization of baseline factors associated with treatm..:

Barbaliscia, S. ; Di Maio, V.C. ; Teti, E....
Digestive and Liver Disease. 51 (2019) - p. e65-e66 , 2019

Link: https://doi.org/10.1016/..

4

Resistance test guided retreatment of HCV infected patients..:

Di Maio, V.C. ; Aragri, M. ; Masetti, C....
Digestive and Liver Disease. 51 (2019) - p. e53-e54 , 2019

Link: https://doi.org/10.1016/..

5

Comparison of resistance profiles among DAA-naive and DAA-e..:

Maio, V.C.D. ; Barbaliscia, S. ; Teti, E....
Journal of Hepatology. 68 (2018) - p. S262-S263 , 2018

Link: https://doi.org/10.1016/..

6

Characterization of resistance profiles in HCV 2-3-4 DAA-na..:

Barbaliscia, S. ; Di Maio, V.C. ; Teti, E....
Digestive and Liver Disease. 50 (2018) 1 - p. 46-47 , 2018

Link: https://doi.org/10.1016/..

7

Multiclass hepatitis C virus resistance to direct acting an..:

Di Maio, V.C. ; Cento, V. ; Lenci, I....
Journal of Hepatology. 66 (2017) 1 - p. S82-S83 , 2017

Link: https://doi.org/10.1016/..

8

HCV resistance test guided retreatments after protease inhi..:

Cento, V. ; Barbaliscia, S. ; Lenci, I....
Digestive and Liver Disease. 49 (2017) 1 - p. e53 , 2017

Link: https://doi.org/10.1016/..

9

The challenge of HCV-retreatment after DAA-failure: real-li..:

Cento, V. ; Barbaliscia, S. ; Di Maio, V.C....
Journal of Hepatology. 66 (2017) 1 - p. S744-S745 , 2017

Link: https://doi.org/10.1016/..

10

Prevalence and characteristics of resistance associated sub..:

Di Maio, V.C. ; Barbaliscia, S. ; Lenci, I....
Digestive and Liver Disease. 49 (2017) 1 - p. e62-e63 , 2017

Link: https://doi.org/10.1016/..

11

Multiclass HCV resistance to interferon-free direct acting ..:

Di Maio, V.C. ; Cento, V. ; Lenci, I....
Digestive and Liver Disease. 49 (2017) 1 - p. e49-e50 , 2017

Link: https://doi.org/10.1016/..

12

The challenge of HCV-retreatment after DAA-failure: Italian..:

Cento, V. ; Barbaliscia, S. ; Di Maio, V.C....
Digestive and Liver Disease. 49 (2017) 1 - p. e8 , 2017

Link: https://doi.org/10.1016/..

13

Impact of analytical treatment interruption on burden and d..:

Scutari R ; Costabile V ; Galli L...
info:eu-repo/semantics/altIdentifier/pmid/34372609. , 2021

Link: http://hdl.handle.net/24..

14

Frequent NS5A and multiclass resistance in almost all HCV g..:

Di Maio V. C ; Cento V ; Aragri M...
info:eu-repo/semantics/altIdentifier/pmid/28939133. , 2018

Link: http://hdl.handle.net/11..

15

Optimal efficacy of interferon-free HCV retreatment after p..:

Cento, V ; Barbaliscia, S ; Lenci, I...
info:eu-repo/semantics/altIdentifier/pmid/28412381. , 2017

Link: http://hdl.handle.net/24..